Many more children suffer from myopia than was the case 50 years ago: in parts of Asia, over 70% of children are now myopic and require some form of refractive correction to see clearly. A vast literature on possible causes of myopia and methods for controlling myopia progression has built up over the years and, until recently, distinguishing between hypothesis and real evidence has posed a significant challenge. Recent clinical trials of a variety of methods for controlling myopia progression have shown encouraging results and several methods are becoming commercially available. This article addresses the question: should we now be attempting to control myopia progression in a clinical setting? If so, what are the options?